You have searched for "Vaccine"
Showing 1-10 of 4253
BRUSSELS (Reuters) - The European Commission launched a new global fundraising campaign on Thursday to finance the development and worldwide distribution of testing, vaccines and treatments against COVID-19, seeking to address concerns they may not be equally shared.
(Reuters) - The chief executive of AstraZeneca
ZURICH (Reuters) - Novartis's gene therapy unit AveXis has signed a manufacturing agreement to produce a novel genetic COVID-19 vaccine being developed by the U.S.-based Mass General Brigham health care system, a spokeswoman for the Swiss drugmaker said on Thursday.
VIENNA (Reuters) - Nobody will get preferential access to a potential COVID-19 drug developed by vaccine maker Themis Bioscience, which is being bought by U.S. pharmaceuticals firm Merck & Co Inc
LONDON (Reuters) - British drugmaker GSK
HONG KONG (AFP): Optimism over the reopening of major economies across the planet helped push most markets higher Thursday (May 28), as investors looked past building China-US tensions for now, though there remain worries about the uncertain global outlook.
BENGALURU: Britain's GlaxoSmithKline laid out plans on Thursday to produce 1 billion doses of vaccine efficacy boosters, or adjuvants, next year as the race to develop and produce a successful solution to the coronavirus crisis heats up.
KUALA LUMPUR: The FBM KLCI erased its early headway to retreat to the 1,450 level as investors remained cautious at the psychological support.
As the novel coronavirus wreaks global havoc, Bill Gates is the new bete noire for conspiracy theorists worldwide including in Africa where a Kenyan politician’s false online post has added major fuel to the spread of misinformation.